BioCentury
ARTICLE | Financial News

Bridge Biotherapeutics completes venture financing

August 8, 2016 7:00 AM UTC

Bridge Biotherapeutics Inc., Seongnam, South Korea Business: Autoimmune, Inflammation, Ophthalmic Date completed: 2016-07-29 Type: Venture financing Raised: $12.6 million Investors: LBInvestment; KB I...